Hematological Oncology
 2023
DOI: 10.1002/hon.3165_526
|View full text |Cite
|
Sign up to set email alerts
|

Prospective Real World Evidence: Use of Brentuximab Vedotin as Consolidation Therapy After Autologous Transplant in Hodgkin Lymphoma. An Interim Analysis, on Behalf of Gatla

Lorena Fiad
1
,
J L Altuve
2
,
A. Cerutti
3
et al.
Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles

scite logo

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations鈥揷itations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Product
Browser ExtensionAssistant by sciteCitation Statement SearchReference CheckVisualizationsDashboardsExplore JournalsExplore OrganizationsExplore FundersEmbedding BadgeEmbedding Citation SearchPricing
Resources
BlogHelp & FAQAccessibility StatementAPI TermsFor Universities & GovernmentsFor ResearchersFor PublishersFor Corporate, Pharma & EnterpriseAuthor MarketingBecome an AffiliateGet an organization trial or quotescite Data & Services
About
News & PressCareersRead our PaperCoverage

BlogTerms and ConditionsAPI TermsPrivacy PolicyContactCookie PreferencesDo Not Sell or Share My Personal Information

Copyright 漏 2024 scite LLC. All rights reserved.

Made with 馃挋 for researchers

Part of the Research Solutions Family.